North America transthyretin amyloidosis treatment market statistics, by country, 2018-2030 (USD Million)
North America transthyretin amyloidosis treatment market outlook size was valued at 2,426.6 USD million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 14.3% from 2024 to 2030.